BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 18789119)

  • 1. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A; Salooja N; Russell-Jones R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
    Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
    Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology.
    Tsirigotis P; Kapsimalli V; Baltadakis I; Kaloyannidis P; Karakasis D; Papalexandri A; Psarra E; Nosi E; Konsta E; Vikentiou M; Papageorgiou S; Sakellari I; Pappa V; Harhalakis N; Anagnostopoulos A; Dervenoulas J
    Transfus Apher Sci; 2012 Apr; 46(2):181-8. PubMed ID: 22115608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
    George JF; Gooden CW; Guo L; Kirklin JK
    J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
    Mutis T; Aarts-Riemens T; Verdonck LF
    Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells.
    Di Biaso I; Di Maio L; Bugarin C; Gaipa G; Dander E; Balduzzi A; Parma M; D'Amico G; Perseghin P; Biondi A; Biagi E
    Transplantation; 2009 May; 87(9):1422-5. PubMed ID: 19424046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
    Rao V; Saunes M; Jørstad S; Moen T
    Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T Cells in Chronic Graft-Versus-Host Disease After Extracorporeal Photopheresis: Correlation With Skin and Global Organ Responses, and Ability to Taper Steroids.
    Denney HA; Whittle RJ; Lai J; Jacques RM; Taylor PC
    Transplantation; 2017 Jan; 101(1):204-211. PubMed ID: 27007227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy.
    Rubegni P; Sbano P; Cevenini G; Perari MG; Marotta G; Risulo M; Carcagnì MR; D' Ascenzo G; De Aloe G; Fimiani M
    Int J Immunopathol Pharmacol; 2007; 20(4):801-7. PubMed ID: 18179753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients.
    Meloni F; Cascina A; Miserere S; Perotti C; Vitulo P; Fietta AM
    Transplant Proc; 2007; 39(1):213-7. PubMed ID: 17275508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.
    Meignin V; Peffault de Latour R; Zuber J; Régnault A; Mounier N; Lemaître F; Dastot H; Itzykson R; Devergie A; Cumano A; Gluckman E; Janin A; Bandeira A; Socié G
    Exp Hematol; 2005 Aug; 33(8):894-900. PubMed ID: 16038781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes.
    Bladon J; Taylor PC
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):293-302. PubMed ID: 16313240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
    González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F
    Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.
    Ukena SN; Grosse J; Mischak-Weissinger E; Buchholz S; Stadler M; Ganser A; Franzke A
    Ann Hematol; 2011 Feb; 90(2):213-8. PubMed ID: 20859740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.